ערך בספרים למניה: scPharmaceuticals, Inc. (SCPH)
The daily price chart for scPharmaceuticals Inc. (SCPH) reflects the performance of the company developing drug delivery systems. The indicator stands at -0.40. The business relies on patents for subcutaneous administration of cardiac medications, which creates high barriers to entry for competitors due to stringent FDA requirements. Risks include logistical disruptions and geopolitical tensions complicating international certification. Protection against replication has been strengthened by the success of the Furoscix patch, which reduces hospital expenses.
%3A%20%D7%A2%D7%A8%D7%9A%20%D7%97%D7%A9%D7%91%D7%95%D7%A0%D7%90%D7%99%20%D7%A9%D7%9C%20%D7%9E%D7%A0%D7%99%D7%94&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_SCPH_-_scPharmaceuticals-Inc._-_Accounting-Value-of-a-Share "SCPH (scPharmaceuticals, Inc.) היסטוריית נכסים נקיים למניה בודדת מ-04.07.2022 עד 18.10.2025 | 👁️GURU.Markets👁️")
scPharmaceuticals, Inc. - פילוחים אנליטיים ומדדי מפתח (SCPH)
The commercialization of FUROSCIX for the treatment of heart failure determines the financial stability of scPharmaceuticals Inc. (SCPH), as clearly reflected in the book value per share chart. This indicator is calculated as the ratio of equity to the number of issued shares, allowing investors to assess the real value of net assets and identify risks of share dilution or asset impairment.